Jade Biosciences to Participate in Two Upcoming Investor Conferences
Globenewswire·2025-07-08 19:00
Jade's Chief Executive Officer, Tom Frohlich, and Chief Scientific Officer and Head of R&D, Andrew King, BVMS, Ph.D., will participate in a fireside chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference on July 14, 2025, starting at 3:00 p.m. ET. A live webcast will be available on the Investors & Media section of Jade's website, with an archived replay accessible for 90 days following the event. SAN FRANCISCO and VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, In ...